S100B and melanoma: In some cases, the level of these biomarkers can be used for prognostic purposes—in stage IV melanoma patients, the melanoma biomarkers MIA and S100B are raised and detectable in EVs from their sera; raised levels of these biomarkers are also associated with shorter median survival.93